Validation of the OMRON M7 (HEM-780-E) blood pressure measuring device in a population requiring large cuff use according to the International Protocol of the European Society of Hypertension
- PMID: 17496467
- DOI: 10.1097/MBP.0b013e3280b08367
Validation of the OMRON M7 (HEM-780-E) blood pressure measuring device in a population requiring large cuff use according to the International Protocol of the European Society of Hypertension
Abstract
Background: A high percentage of hypertensive patients present an arm circumference of over 32 cm; the use of a large cuff is therefore recommended. Validation studies are usually performed in the general population using a standard-size cuff. The aim of this study was to assess the accuracy of the Omron M7 device in a population with an arm circumference ranging from 32 to 42 cm.
Design: A validation study was performed according to the International Protocol of the European Society of Hypertension. This protocol is divided into two phases: the first phase is performed on 15 selected participants (45 pairs of blood-pressure measurements); if the device passes this phase, 18 supplementary participants are included (54 pairs of blood-pressure measurements), making a total number of 33 participants (99 pairs of blood-pressure measurements), on whom the analysis is performed.
Methods: For each participant, four blood-pressure measurements were performed simultaneously by two trained observers, using mercury sphygmomanometers fitted with a Y tube; the measurements alternated with three by the test device. The difference between the blood-pressure value given by the device and that obtained by the two observers (mean of the two observations) was calculated for each measure. The 99 pairs of blood-pressure differences were classified into three categories (<or=5, <or=10 and <or=15 mmHg). The number of differences in each category was compared with the number required by the European Society of Hypertension protocol.
Results: The Omron M7 device passed the first and the second phases of the validation process. The average differences between the two observers were 1.5+/-3.2 and -0.5+/-2.2 mmHg for systolic blood pressure and diastolic blood pressure, and those between the device and the mercury sphygmomanometer were -1.6+/-6.7 for systolic blood pressure and -0.12+/-4.0 mmHg for diastolic blood pressure Readings that differ by less than 5, 10 and 15 mmHg for systolic blood-pressure and diastolic blood-pressure values fulfill the recommendation criteria of the European Society of Hypertension protocol.
Conclusions: The Omron M7 (HEM-780-E) device fulfilled the validation criteria of the international protocol in a population with an arm circumference ranging from 32 to 42 cm.
Similar articles
-
Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT).Blood Press Monit. 2006 Jun;11(3):165-71. doi: 10.1097/01.mbp.0000209078.17246.34. Blood Press Monit. 2006. PMID: 16702826
-
Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension.Blood Press Monit. 2007 Aug;12(4):233-42. doi: 10.1097/MBP.0b013e32813fa386. Blood Press Monit. 2007. PMID: 17625396
-
Validation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-7051-E), the Omron M2 Compact (HEM 7102-E), and the Omron R3-I Plus (HEM 6022-E).Blood Press Monit. 2010 Feb;15(1):49-54. doi: 10.1097/MBP.0b013e3283354b11. Blood Press Monit. 2010. PMID: 20032779 Clinical Trial.
-
User procedure for self-measurement of blood pressure. First International Consensus Conference on Self Blood Pressure Measurement.Blood Press Monit. 2000 Apr;5(2):111-29. Blood Press Monit. 2000. PMID: 10828898 Review.
-
Demise of the mercury sphygmomanometer and the dawning of a new era in blood pressure measurement.Blood Press Monit. 2003 Feb;8(1):19-21. doi: 10.1097/01.mbp.0000057012.67622.de. Blood Press Monit. 2003. PMID: 12604931 Review.
Cited by
-
Standing up against office sitting: A study protocol.S Afr J Physiother. 2020 Sep 4;76(1):1415. doi: 10.4102/sajp.v76i1.1415. eCollection 2020. S Afr J Physiother. 2020. PMID: 32935066 Free PMC article. Clinical Trial.
-
Arterial Stiffness Is Associated With Cytomegalovirus-Specific Senescent CD8+ T Cells.J Am Heart Assoc. 2017 Aug 28;6(9):e006535. doi: 10.1161/JAHA.117.006535. J Am Heart Assoc. 2017. PMID: 28847915 Free PMC article.
-
Questionable accuracy of home blood pressure measurements in the obese population - Validation of the Microlife WatchBP O3® and Omron RS6® devices according to the European Society of Hypertension-International Protocol.Vasc Health Risk Manag. 2017 Feb 27;13:61-69. doi: 10.2147/VHRM.S126285. eCollection 2017. Vasc Health Risk Manag. 2017. PMID: 28280348 Free PMC article.
-
Effects of high-intensity interval and moderate-intensity continuous training on ambulatory blood pressure and cardiovascular outcomes in older adults with hypertension (HEXA Study): study protocol for a randomised trial.BMJ Open. 2024 Dec 20;14(12):e084736. doi: 10.1136/bmjopen-2024-084736. BMJ Open. 2024. PMID: 39806596 Free PMC article.
-
Effectiveness of exercise at workplace in physical fitness: uncontrolled randomized study.Einstein (Sao Paulo). 2014 Jan-Mar;12(1):55-60. doi: 10.1590/s1679-45082014ao2956. Einstein (Sao Paulo). 2014. PMID: 24728247 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources